Current concepts on the pathogenesis of Escherichia coli meningitis: Implications for therapy and prevention

Current Opinion in Infectious Diseases

Volumn 25, Issue 3, 2012, Pages 273-278

  Kim, Kwang S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotic resistance; blood brain barrier; Escherichia coli meningitis; microbial host factors

Indexed keywords

BACTEREMIA; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOOD BRAIN BARRIER; HOST PATHOGEN INTERACTION; HUMAN; INFECTION PREVENTION; NEUROTROPISM; NEWBORN; NEWBORN INFECTION; NONHUMAN; PATHOGENESIS; REVIEW;

BLOOD-BRAIN BARRIER; ENDOTHELIAL CELLS; ESCHERICHIA COLI; HUMANS; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MENINGITIS, ESCHERICHIA COLI;

EID: 84862821557     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283521eb0     Document Type: Review

References (35)

1. Thigpen MC, Whitney CG, Messonnier NE. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011; 364:2016-2025.
2. Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease- revised guidelines from CDC. MMWR Recomm Rep 2010; 59:1-36.
3. Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008; 121:689-696.
4. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011; 30:937-941.
5. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: The burden of group B streptococcal and E. coli disease continues. Pediatrics 2011; 127:817-826.
6. Gaschignard J, Levy C, Romain O, et al. Neonatal bacterial meningitis. Pediatr Infect Dis J 2011; 30:212-217.
7. Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis 2010; 10:32-42. This review article summarized the current concept on the epidemiology, pathogenesis, prevention and therapy of acute bacterial meningitis in infants and children.
8. Moissenet D, Slauze B, Clermont O, et al. Meningitis caused by Escherichia coli producing TEM-52 extended-spectrum b-lactamase within an extensive outbreak in a neonatal ward: Epidemiological investigation and characterization of the strain. J Clin Microbiol 2011; 48:2459-2463.
9. Blanco J, Mora A, Mamani R, et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H5-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother 2011; 66:2011-2012.
10. Yamamoto T, Takano T, Iwao Y, Hishinuma A. Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan. J Infect Chemother 2011; 17:435-439.
11. Birgy A, Doit C, Mariani-Kurkdjian P, et al. Early detection of colonization by VIM-1-producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol 2011; 49:3085-3087.
12. Kim KS. Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol 2008; 6:625-634.
13. Kim KS. Neurological diseases: Pathogenesis of bacterial meningitis: From bacteremia to neuronal injury. Nat Rev Neurosci 2003; 4:376-385.
14. Mittal R, Gonzalez-Gomez I, Panigrahy A, et al. IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis. J Exp Med 2010; 207:1307-1319.
15. Chi F, Wang L, Zheng X, et al. Meningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotine receptor. PLoS One 2011; 6:e25016.
16. Moriel DG, Bertoldi I, Spagnuolo A, et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci U S A 2010; 107:9072-9077.
17. Xie Y, Kolisnychenko V, Paul-Satyassela M, et al. Identification and characterization of E. coli RS 218-derived islands in the pathogenesis of E. coli meningitis. J Infect Dis 2006; 194:358-364.
18. Wieser A, Magistro G, Norenberg D, et al. First multiepitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS). Int J Med Microbiol 2012; 302:10-18.
19. Teng C, Tseng Y, Pearce D, et al. NlpI contributes to Escherichia coli K1 strain RS218 interaction with human brain microvascular endothelial cells. Infect Immun 2010; 78:3090-3096.
20. Maruvada R, Kim KS. Extracellular loops of the E coli outer membrane protein A contribute to the pathogenesis of meningitis. J Infect Dis 2011; 203:131-140.
21. Teng CH, Xie Y, Shin S, et al. Effects of ompA deletion on Escherichia coli K1 strain RS218's type 1 fimbria expression and association with human brain microvascular endothelial cells. Infect Immun 2006; 74:5609-5616.
22. Shin S, Kim KS. Human brain endothelial ATP synthase b-subunit is mannose-insensitive binding target of FimH. FEMS Microbiol Lett 2010; 303:156-162.
23. Zhao WD, Liu W, Fang WG, et al. Vascular endothelial growth factor receptor 1 contributes to Escherichia coli K1 invasion of human brain microvascular endothelial cells through PI3K/Akt signaling pathway. Infect Immun 2010; 78:4809-4816.
24. Korczak B, Frey J, Schrenzel J, et al. Use of diagnostic microarrays for determination of virulence gene patterns of Escherichia coli K1, a major cause of neonatal meningitis. J Clin Microbiol 2005; 43:1024-1031.
25. Lu S, Zhang X, Zhu Y, et al. Complete genome sequence of the neonatal meningitis-associated Escherichia coli strain CE10. J Bacteriol 2011; 193:7005.
26. Zhu L, Maruvada R, Sapirstein A, et al. Arachidonic acid metabolism regulates Escherichia coli penetration of the blood-brain barrier. Infect Immun 2010; 78:4302-4310. This study demonstrates the contribution of arachidonic acid metabolism to E. coli penetration specifically into the brain.
27. Zhu L, Pearce D, Kim KS. Prevention of E. coli K1 penetration of the bloodbrain barrier by counteracting host cell receptor and signaling molecule involved in E. coli invasion of human brain microvascular endothelial cells. Infect Immun 2010; 78:3554-3559.
28. Yu H, Kim KS. Ferredoxin is involved in secretion of cytotoxic necrotizing factor 1 across the cytoplasmic membrane in Escherichia coli K1. Infect Immun 2010; 78:838-844.
29. Yu H, Kim KS. YgfZ contributes to secretion of cytotoxic necrotizing factor 1 into outer membrane vesicles in Escherichia coli. Microbiology 2012; 158:612-621.
30. Yu H, Kim KS. The involvement of SelB in expression of cytotoxic necrotizing factor 1 in Escherichia coli. FEBS Lett 2011; 585:1934-1940.
31. Yu H, Kim KS. mRNA context dependent regulation of cytotoxic necrotizing factor 1 translation by GidA, a tRNA modification enzyme in Escherichia coli. Gene 2012; 491:116-122.
32. Zhou Y, Yao J, Yu H, et al. Hcp-family proteins secreted via type VI secretion system coordinately regulate Escherichia coli K1 interaction with human brain microvascular endothelial cells. Infect Immun 2012; 80:1243-1251.
33. Liu S, Li L, Luo Z, et al. Superior effect of hypertonic saline over mannitol to attenuate cerebral edema in a rabbit bacterial meningitis model. Crit Care Med 2011; 39:1467-1473.
34. Gerber J, Tauber SC, Armbrecht I, et al. Increased neuronal proliferation in human bacterial meningitis. Neurology 2009; 73:1026-1032.
35. Hofer S, Grandgirard D, Burri D, et al. Bacterial meningitis impairs hippocampal neurogenesis. J Neuropathol Exp Neurol 2011; 70:890-899.